1
Reply to Eaton Et al., oral surgery, 22(0), 2025
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Dr. Öğr. Üyesi Sibel Başçil, Doç Dr Nilufer Kılıç Durankuş |
2
The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients, Tomography, 10(1), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Dr. Öğr. Üyesi Umur Anil Pehlivan, Doç Dr Busra Yılmaz, Doç Dr Ali Ayberk Besen, Prof Dr Hüseyin Mertsoylu, Prof Dr Berrin Pehlivan, Prof Dr Ugur Selek |
3
Comment on Survivin -31G/C polymorphism and disease fate in of oral squamous cell carcinomas, Journal of Stomatology Oral and Maxillofacial Surgery, 12(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Prof Dr Uğur Selek |
4
Comment on: Assessment of Prevalence and Factors Affecting Trismus in Cases of Oral and Oropharyngeal Malignancies after Complete Treatment, Indian Journal of Otolaryngology and Head & Neck Surgery, 12(0), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Dr. Öğretim Üyesi Duriye Ozturk, Prof Dr Ugur Selek |
5
The presence of myopenia alone is not sufficient for a diagnosis of sarcopenia, Japanese Journal of Radiology, 6(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Dr. Öğretim Üyesi Şükran Şenyürek |
6
RE: Impact of Cancer Localization on Symptom Burden and Quality of Life in Head and Neck Cancers: A Comparative Study, Ear Nose and Throat, 11(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Prof Dr Ugur Selek |
7
Comment on `Osteoradionecrosis incidence in pre- radiation teeth extractions: A prospective study, ORAL DISEASES, 3(0), 2024
Doç. Dr. Efsun Somay, Dr Öğr Üyesi Düriye Öztürk, Prof. Dr. Erkan Topkan |
8
Evidence-based Practical Recommendations for Prevention and Management of Radiation-induced Trismus, Turkish Journal of Oncology, 39(4), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Dr. Nilufer Kılıç Durankuş, Dr. Şükran Şenyürek, Dr. Öğr. Üyesi Sibel Başçil, Prof Dr Ugur Selek |
9
Topkan~'~s CARWL Index Efficiently Predicts the Radiation-Induced Tooth Loss Rates in Radically Treated Locally Advanced Nasopharyngeal Cancer Patients, TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 23(0), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Dr. Öğr. Üyesi Sibel Başçil, Dr. Duriye Öztürk, Dr. Sükran Senyürek, Dr. Nilüfer Kılıç Durankus, Prof Dr Ugur Selek |
10
Underrated But Significant Risk Factors of Osteoradionecrosis of the Jaw in Patients With Head and Neck Cancer, JOURNAL OF CLINICAL ONCOLOGY, 11(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Dr. Öğr. Üyesi Sibel Başçil, Prof.Dr.Berrin Pehlivan |
11
Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer, International Journal of Surgical Oncology, 11(0), 2024
Doç. Dr. Efsun Somay, Doç. Dr Büşra Yılmaz, Prof. Dr. Erkan Topkan, Doç Dr Beyza Sirin Özdemir, Dr. Öğr. Üyesi. Duriye Özturk, Doç. Dr Ali Ayberk Besen, Prof Dr Hüseyin Mertsoylu, Prof Dr Ugur Selek |
12
The Impact of Oral Health and Antibiotics on the Outcomes of Head and Neck Cancer Patients Receiving Anticancer Therapies: Two Interrelated Conditions, Acta Scientific Dental Sciences, 8(11), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Dr. Öğr. Üyesi Sibel Başçil, Dr. Duriye Ozturk, Dr Sukran Senyurek, Prof Dr Ugur Selek |
13
Comment on: Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer, RADIOTHERAPY AND ONCOLOGY, 22(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Prof Dr Ugur Selek |
14
Comment on:The relevance of dental management prior to radiation therapy with severe oral mucositis in head and neck cancer patients., Journal of Dental Sciences, 19(4), 2024
Prof. Dr. Erkan Topkan, Dr. Öğr. Üyesi Sibel Başçil, Prof.Dr.Ugur Selek |
15
In regard to Castagnola et al. (doi: 10.1186/ s12903-023-03050-7), BMC Oral Health, 23(0), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Prof Dr Ugur Selek |
16
The Prediction of Radiation-Induced Trismus by the Apparent Diffusion Coefficient Values of Masseter Muscles before Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinomas, Diagnostics, 24(0), 2024
Dr. Öğr. Üyesi Umur Anil Pehlivan, Doç. Dr. Efsun Somay, Öğr.Gör.Dr. Çiğdem Yalçin Ulaş, Prof. Dr. Erkan Topkan |
17
Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: the value of the CARWL index, biomolecules and biomedicine, 25(1), 2024
Dr. Öğr. Üyesi. Nilüfer Kılç Durankuş, Doç. Dr. Efsun Somay, Dr. Öğr. Üyesi Sibel Başçil, Dr. Öğr. Üyesi. Şükran Şenyürek, Dr. Öğr. Üyesi. Düriye Öztürk, Prof Dr Ugur Selek, Prof. Dr. Erkan Topkan |
18
The unique CARWL score stratifies locally advanced nasopharyngeal cancer patients receiving concurrent chemoradiotherapy into risk groups for radiation-induced trismus, Discover Oncology, 15(1), 2024
Dr Sükran Senyurek, Doç. Dr. Efsun Somay, Dr Nilufer Kılıç Durankuş, Dr. Öğr. Üyesi Sibel Başçil, Dr. Duriye Öztürk, Prof Dr Ugur Selek, Prof. Dr. Erkan Topkan |
19
Radiation-Induced Changes in the Temporomandibular Joint and Synovial Fluid Leading to Radiation-Induced Trismus, Acta Scientific Dental Sciences, 8(7), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Dr. Öğr. Üyesi Sibel Başçil, Prof Dr Ugur Selek |
20
Periodontitis can Negatively Impact the Survival Outcomes of Cancer Patients, oral oncology reports, 10(0), 2024
Doç. Dr. Efsun Somay, Dr. Öğr. Üyesi Sibel Başçil, Dr.Öğr.Üyesi Düriye Öztürk, Prof. Dr. Erkan Topkan |
21
Comment on prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers , ORAL ONCOLOGY, 155(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Dr. Öğr. Üyesi Sibel Başçil, Prof Dr Ugur Selek |
22
PRE-CHEMORADIOTHERAPY HIGH PLATELET COUNTS PREDICT JAW OSTEORADIONECROSIS IN LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMAPATIENTS, Journal of Stomatology Oral and Maxillofacial Surgery, 23(0), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Doç Dr Ahmet Küçük, Dr. Öğr.Üyesi.Düriye Öztürk, Doç Dr. Emine Elif Özkan, Doç Dr Beyza Özdemir, Doç. Dr Ali Ayberk Beşen, Prof Dr Hüseyin Mertsoylu, Prof Dr Berrin Pehlivan, Prof Dr Uğur Selek |
23
Comment on: Does the Planning Target Volume Correlate with Toxicity for Head and Neck Cancer Patients Undergoing Radiation? A Prospective Observational Study, Indian Journal of Surgical Oncology, 21(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Ali Ayberk Besen, Prof Dr Hüseyin Mertsoylu |
24
Comment on Kittichet et al. (doi: 10.1111/odi.14905), ORAL DISEASES, 21(0), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Prof Dr Berrin Pehlivan, Prof Dr Ugur Selek |
25
Letter to Editor: ?The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Its Influencing Factors?, Ear Nose and Throat, 21(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Ali Ayberk Besen, Prof Dr Hüseyin Mertsoylu |
26
Global immune-nutrition-inflammation index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients, Biomolecules&Biomedicine, 24(6), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Dr. Öğr. Üyesi Sibel Başçil, Dr. Öğr.Üyesi Nilüfer Durankuş, Dr. Öğr.Üyesi. Şükran Şenyürek, Dr. Öğr.Üyesi.Düriye Öztürk, Prof Dr Berrin Pehlivan, Prof Dr Ugur Selek |
27
The Ongoing Unnecessary Debate Regarding the Risk Factors for Osteoradionecrosis of the Jaw: Prescription Dose versus Mandibular Doses, oral oncology reports, 10(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Dr Öğr Üyesi Düriye Öztürk, Dr. Öğr. Üyesi Sibel Başçil, Prof Dr Uğur Selek |
28
Toxicities and prognostic factors in elderly HPV?associated oropharyngeal cancer patients treated with radiotherapy or chemoradiotherapy, journal of medical virology, 1(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Prof. Dr . Ugur Selek |
29
Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas, International Journal of Biological Markers, 9(0), 2024
Doç. Dr. Efsun Somay, Doç Dr Busra Yılmaz, Prof. Dr. Erkan Topkan, Doç. Dr. Beyza Sirin Ozdemir, Dr.Öğr.Üyesi. Düriye Öztürk, Doç. Dr Ali Ayberk Besen, Prof Dr Hüseyin Mertsoylu, Prof. Dr. Ugur Selek |
30
Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy, Journal of Clinical Medicine, 14(0), 2024
Doç Dr Büşra Yılmaz, Doç Dr Ali Ayberk Besen, Prof Dr Hüseyin Mertsoylu, Prof Dr Ugur Selek, Prof. Dr. Erkan Topkan |
31
Comment on: Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry, Pediatric Blood & Cancer, 13(1), 2024
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Prof Dr Ugur Selek |
32
Comment on: Risk prediction of complicated course in patients undergoing major head and neck surgery with free flap reconstruction, BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 11(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Dr. Duriye Ozturk, Dr Sukran Senyürek |
33
Causes of Delays in Starting Postoperative Radiotherapy Among Head and Neck Cancer Patients, OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 21(0), 2024
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Prof Dr Ugur Selek |
34
Predicting Teeth Extraction after Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer Patients Using the Novel GLUCAR Index, Diagnostics, 21(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Doç Dr Büşra Yılmaz, Doç Dr Ali Ayberk Besen, Prof Dr Hüseyin Mertsoylu, Prof Dr Ugur Selek |
35
Comment on: The extent of unnecessary tooth loss due to extractions prior to radiotherapy based on radiation field and dose in patients with head and neck cancer, RADIOTHERAPY AND ONCOLOGY, 13(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Prof Dr Ugur Selek |
36
Toxicity with proton therapy for oral and/or oropharyngeal cancers, JOURNAL OF ORAL PATHOLOGY & MEDICINE, 52(0), 2023
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz, Prof Dr Uğur Selek |
37
RE: Is Dose Volume a Better Predictor of Osteoradionecrosis Risk Than Total Dose for Patients Who Have Received Head and Neck Radiation?, JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 81(0), 2023
Prof. Dr. Erkan Topkan, Doç Dr Büşra Yılmaz, Doç Dr Efsun Somay, Doç Dr Ahmet Küçük, Doç. Dr. Efsun Somay |
38
In Reference to Difficult Tracheal Intubation and Airway Outcomes After Radiation for Nasopharyngeal Carcinoma, LARYNGOSCOPE, 23(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Prof Dr Ugur Selek |
39
In Regard to Anderson et al, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 115(0), 2023
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz |
40
Comment on: Quality of life after segmental mandibulectomy and free flap for mandibular osteonecrosis: Systematic review, AMERICAN JOURNAL OF OTOLARYNGOLOGY, 44(0), 2023
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay |
41
Comment on "Osteoradionecrosis versus Cancer Recurrence: An Unresolved Clinical Dilemma" (DOI: 10.1159/000527261), ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery, 85(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Doç Dr Ahmet Küçük, Prof Dr Uğur Selek |
42
In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8), EJNMMI Research, 13(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Prof Dr Berrin Pehlivan, Prof Dr Uğur Selek |
43
The predictive usefulness of the novel "combined hemoglobin-to-platelet ratio and maximum mouth opening index" on prevalence of radiation induced trismus in patients with nasopharyngeal cancer, HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 45(0), 2023
Doç Dr Efsun Somay, Doç. Dr Büşra Yılmaz, Prof. Dr. Erkan Topkan, Doç. Dr Ahmet Küçük, Prof Dr Berrin Pehlivan, Prof . Dr Uğur Selek |
44
Comment on: Evaluation of halitosis parameters in patients undergoing head and neck radiotherapy, ORAL DISEASES, 13(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Prof Dr Uğur Selek |
45
Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients, EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 280(0), 2023
Doç Dr Büşra Yılmaz, Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Prof Dr Berrin Pehlivan, Prof Dr Uğur Selek |
46
The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy, BMC Oral Health, 23(0), 2023
Doç. Dr Büşra Yılmaz, Doç Dr Efsun Somay, Prof. Dr. Erkan Topkan, Doç. Dr Ahmet Küçük, Prof Dr Berrin Pehlivan, Prof Dr Uğur Selek |
47
Letter to editor in regard to Sunderasan et al. (https://doi.org/10.1111/scd.12801), Special Care in Dentistry, 30(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan |
48
Letter to the Editor regarding "Long?term swallow outcomes and factors affecting swallowing dysfunction and quality of life among oral cancer patients: a prospective observational study" by Thaduri et al. Eur Arch Otorhinolaryngol. 2023 Aug 7. doi: 10.1007/s00405-023-08155-x, EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 18(0), 2023
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Prof Dr Ugur Selek |
49
Comment on: Quality of life after segmental mandibulectomy and free flap for mandibular osteonecrosis: Systematic review, AMERICAN JOURNAL OF OTOLARYNGOLOGY, 44(0), 2023
Prof. Dr. Erkan Topkan |
50
In Regard to Nath et al. (2022) (doi: 10.1007/s12070-021-02941-x), Indian Journal of Otolaryngology and Head & Neck Surgery, 75(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan |
51
Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors, Journal of Clinical Medicine, 12(0), 2023
Prof. Dr. Erkan Topkan, Doç Dr Ahmet Küçük, Doç Dr Efsun Somay, Doç Dr Büşra Yılmaz, Prof Dr Berrin Pehlivan, Prof Dr Uğur Selek, Doç. Dr. Efsun Somay |
52
Comment on: Risk factors for osteoradionecrosis of the jaw in patients with oral or oropharyngeal cancer: Verification of the effect of tooth extraction before radiotherapy using propensity score matching analysis, Journal of Dental Sciences, 2(0), 2023
Doç Dr Büşra Yılmaz, Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan |
53
In reply to Chatzopoulos et. al (https://doi.org/10.1016/j.jormas.2022.10.013), Journal of Stomatology Oral and Maxillofacial Surgery, 124(0), 2023
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay |
54
Response to outcomes of immediate dental implants in vascularised bone flaps for mandibular reconstruction, ANZ JOURNAL OF SURGERY, 93(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan |
55
Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients, BMC CANCER, 23(1), 2023
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Büşra Yilmaz, Prof Dr Berrin Pehlivan, Prof Dr Uğur Selek |
56
The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy, BMC Oral Health, 23(0), 2023
Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz, Prof. Dr. Erkan Topkan, Doç Dr Ahmet Küçük, Prof Dr Berrin Pehlivan, Prof Dr Uğur Selek |
57
Comment on "Trismus surgery and microsurgical reconstruction after oral cancer treatment", JOURNAL OF SURGICAL ONCOLOGY, 127(0), 2023
Doç. Dr. Efsun Somay, Doç Dr Ahmet Küçük, Prof. Dr. Erkan Topkan |
58
In Reply to Saenthaveesuk et al, JDR Clinical & Translational Research, 12(0), 2023
Prof. Dr. Erkan Topkan, Doç Dr Efsun Somay, Prof Dr Uğur Selek, Doç. Dr. Efsun Somay |
59
Letter to the Editor: Comment on Chiu TH, et al. A Comparison Study of Outcomes and Complications Between Marginal Mandibulectomy With or Without Additional Mandibulotomy in Tongue Cancers (Ann Plast Surg. 2023;90(1 suppl 1):S37-S43), ANNALS OF PLASTIC SURGERY, 90(0), 2023
Doç. Dr. Efsun Somay, Doç Dr Ahmet Küçük, Prof. Dr. Erkan Topkan |
60
In regard to recent published study of Lombardi et al. titled 'Pentoxifylline and tocopherol for prevention of osteoradionecrosis in patients who underwent oral surgery: A clinical audit'. (Spec Care Dentist. 2022;10.1111/scd.12759. https://doi.org/10.1111/scd.12759), Special Care in Dentistry, 23(0), 2023
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz |
61
The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation, EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 280(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan |
62
In Regard to Faravel et al. 2022: "Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy", INTEGRATIVE CANCER THERAPIES, 22(0), 2023
Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz, Prof. Dr. Erkan Topkan |
63
RE: What Risk Factors Are Associated With Poorer Quality of Life in Patients with Head and Neck Cancer?, JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 81(0), 2023
Doç. Dr. Efsun Somay, Prof. Dr. Erkan Topkan, Prof Dr Uğur Selek |
64
Letter to the editor: preoperative evaluation of oral hygiene may predict the overall survival of patients with esophageal cancer., Esophagus, 23(0), 2023
Prof. Dr. Erkan Topkan, Doç Dr Busra Yılmaz, Doç. Dr. Efsun Somay |
65
Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial, Europian Journal of Cancer, 21(0), 2023
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Prof Dr Ugur Selek, Prof Berrin Pehlivan |
66
Comment on ?A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer?, ORAL ONCOLOGY, 13(0), 2023
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Prof Uğur Selek |
67
Comment on ?A systematic review and meta-analysis of osteoradionecrosis following proton therapy in patients with head and neck cancer, ORAL ONCOLOGY, 149(0), 2023
Prof. Dr. Erkan Topkan, Prof Dr Ugur Selek |
68
Comments on: Carcinoma buccal mucosa treated with definitive hypofractionated accelerated radiotherapy: a retrospective analysis of treatment outcomes, SINGAPORE MEDICAL JOURNAL, 21(0), 2023
Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz, Prof. Dr. Erkan Topkan, Prof Dr Ugur Selek |
69
Contralateral breast radiation doses in breast cancer patients treated with helical tomotherapy, Medical Dosimetry, 48(1), 2023
Ezgi Oymak 1, Prof. Dr. Erkan Topkan, Recep Bozca 2, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal |
70
Further analysis desirable, BRITISH DENTAL JOURNAL, 12(0), 2022
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz |
71
Initial neutrophil-to-lymphocyte ratio predicts radiation-induced trismus in parotid gland cancer, ORAL DISEASES, 8(0), 2022
Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz, Prof. Dr. Erkan Topkan, Doç Ahmet Küçük, Prof Dr Berrin Pehlivan, Prof Uğur Selek |
72
Low hemoglobin levels predict increased radiation-induced trismus rates in nasopharyngeal cancer, ORAL DISEASES, 21(0), 2022
Doç. Dr. Efsun Somay, Doç. Dr Büşra Yılmaz, Prof. Dr. Erkan Topkan, Prof Dr Berrin Pehlivan, Prof Dr Uğur Selek |
73
Comment on: Required time for pre-oncological dental management - A rapid review of the literature, ORAL ONCOLOGY, 134(0), 2022
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz, Doç. Dr Ahmet Küçük |
74
In reply to Shih YJ et.al. (doi: 10.1111/odi.14349), ORAL DISEASES, 34(0), 2022
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz |
75
In regard to recent published study of Massaccesi et al. titled 'A predictive nomogram for trismus after radiotherapy for head and neck cancer'. (Radiother Oncol. 2022 Jun 2: S0167-8140(22)04137-8. doi: 10.1016/j.radonc.2022.05.031), RADIOTHERAPY AND ONCOLOGY, 25(0), 2022
Prof. Dr. Erkan Topkan, Doç. Dr. Efsun Somay, Doç Dr Büşra Yılmaz |
76
Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy, Therapeutics and Clinical Risk Management, 17(0), 2021
Doç. Dr Büşra Yılmaz, Doç. Dr. Efsun Somay, Prof Dr Uğur Selek, Prof. Dr. Erkan Topkan |
77
Definitive concurrent chemoradiotherapy outcomes in Stage IIIB nonsmall cell lung cancer patients younger than 45 years: A retrospective analysis of 145 patients, Journal of Cancer Research and Therapeutics, 16(4), 2020
Prof. Dr. Erkan Topkan, Prof. Dr. Ozan Cem Güler, Doç. Dr. Yurday Özdemir |
78
Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy., CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 13(0), 2020
Prof. Dr. Erkan Topkan, Uğur Selek, Hüseyin Mertsoylu, Doç. Dr. Yurday Özdemir, Ahmet Küçük, Doç. Dr. Neşe Torun, Ali Ayberk Beşen |
79
Local Control and Vertebral Compression Fractures Following Stereotactic Body Radiotherapy for Spine Metastases, Journal of Bone Oncology, 24(15), 2019
Doç. Dr. Yurday Özdemir, Doç. Dr. Neşe Torun, Prof. Dr. Ozan Cem Güler, Berna Akkuş, Ali Ayberk Beşen, Doç. Dr. Aylin Güneşli, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan |
80
Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide, INDIAN JOURNAL OF CANCER, 56(1), 2019
Prof. Dr. Ozan Cem Güler, Yıldırım Ba, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan |
81
Stereotaktik radyocerrahi uygulanan vertebra metastazlarında yanıt değerlendirmesinde PET-BT?nin yeri, Cukurova Medical Journal, 44(1), 2018
Doç. Dr. Yurday Özdemir, Doç. Dr. Neşe Torun, Prof. Dr. Erkan Topkan |
82
High Prognostic Nutritional Index Relates with Enhanced Survival in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy, Wulfenia, 0(0), 2016
Yıldırım Ba, Özdemir Y, Prof. Dr. Ozan Cem Güler, Prof. Dr. Erkan Topkan |
83
Safety and Palliative Efficacy of Single-Dose 8-Gy Reirradiation for Painful Local Failure in Patients With Stage IV Non-Small Cell Lung Cancer Previously Treated With Radical Chemoradiation Therapy, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 91(4), 2015
Prof. Dr. Erkan Topkan, Yıldırım Ba, Prof. Dr. Ozan Cem Güler, Parlak C, Pehlivan B, Selek U |
84
Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 88(4), 2014
Parlak C, Mertsoylu H, Prof. Dr. Ozan Cem Güler, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan |
85
Comparison of computed tomography- and positron emission tomography-based radiotherapy planning in cholangiocarcinoma, Oncologie, 36(9), 2013
Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan, Prof. Dr. Ali Fuat Yapar, S Topuk, A Yavuz |
86
Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapy., ACTA ONCOLOGICA, 50(8), 2011
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, A Kötek, Uzm.Dr. Birsel Ünal, Prof. Dr. Erkan Topkan, A Yavuz, G Arslan |
87
Protective effects of melatonin and octreotide against radiation-induced intestinal injury., DIGESTIVE DISEASES AND SCIENCES, 56(2), 2011
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Fazilet Kayaselçuk, Prof. Dr. Erkan Topkan, D Bacanlı, A Yavuz |
88
Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy: a dose-volume analysis, Radiation Oncology, 11(0), 2009
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, Prof. Dr. Erkan Topkan, A Yavuz, E Efe, S Sönmez |
89
The effect of concurrent androgen deprivation and 3D conformal radiotherapy on prostate volume and clinical organ doses during the course of treatment in prostate cancer, BRITISH JOURNAL OF RADIOLOGY, 82(0), 2009
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, A Yavuz, G Arslan, Prof. Dr. Erkan Topkan, E Efe |
90
Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses., J Exp Clin Cancer Res, 28(0), 2009
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Hüseyin Cem Önal, A Yavuz, G Arslan, Prof. Dr. Erkan Topkan, B Pehlivan, E Oymak |
91
Managing liver metastases with conformal radiation therapy, J SUPPORT ONCOL, 1(0), 2008
Prof. Dr. Melek Nur Yavuz, Prof. Dr. Erkan Topkan, Prof. Dr. Hüseyin Cem Önal |
BAŞKENT ÜNİVERSİTESİ